Related Experiment Video
Updated: Apr 18, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Catheter ablation of atrial fibrillation in patients with severely impaired left ventricular systolic function
Ken Kato1, Koichiro Ejima2, Noritoshi Fukushima1,3
1Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Insights
Catheter ablation for atrial fibrillation (AF) can improve heart function in patients with severe heart failure (HF). Maintaining sinus rhythm or paroxysmal AF after ablation significantly reduces HF hospitalizations, though repeat procedures are often needed.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Outcomes of catheter ablation for atrial fibrillation (AF) in patients with severely reduced left ventricular ejection fraction (LVEF) are not well-established.
- Heart failure (HF) and AF commonly coexist, negatively impacting patient prognosis.
Purpose of the Study:
- To evaluate the effectiveness of catheter ablation for AF in patients with significantly impaired LVEF (≤ 35%).
- To assess improvements in clinical status, echocardiographic parameters, and HF hospitalizations post-ablation.
Main Methods:
- Retrospective analysis of 18 patients with HF and LVEF ≤ 35% undergoing AF catheter ablation.
- Follow-up included clinical assessment, echocardiography, and monitoring of HF hospitalizations.
- Analysis of outcomes based on rhythm status (sinus rhythm, paroxysmal AF, persistent AF) post-ablation.
Main Results:
- 61% of patients achieved sinus rhythm (SR) after a median follow-up of 21 months, with 9 requiring repeat procedures and 6 using amiodarone.
- In patients achieving SR or paroxysmal AF (67%), LVEF improved significantly (25.8% to 37.0%) and NYHA class decreased (2.3 to 1.5) at 6 months.
- Patients in SR or with paroxysmal AF experienced significantly fewer HF hospitalizations compared to those with recurrent persistent AF (P < 0.01).
Conclusions:
- Catheter ablation of AF can improve clinical status and cardiac function in patients with severely reduced LVEF.
- Achieving and maintaining SR or paroxysmal AF is crucial for favorable outcomes and reduced HF hospitalizations.
- Repeat ablation procedures and antiarrhythmic drugs like amiodarone are frequently necessary for successful AF management in this high-risk population.
Abstract:
Little is known about the outcome of catheter ablation of atrial fibrillation (AF) in patients with heart failure (HF) and a severely reduced left ventricular ejection fraction (LVEF). We aimed to clarify the effectiveness of catheter ablation of AF in patients with a severely low LVEF. This retrospective study included 18 consecutive patients with HF and an LVEF of ≤ 35 % who underwent catheter ablation of AF. We investigated the clinical parameters, echocardiographic parameters and the incidence of hospitalizations for HF. During a median follow-up of 21 months (IQR, 13-40) after the final procedure (9 with repeat procedures), 11 patients (61 %) maintained sinus rhythm (SR) (6 with amiodarone). The LVEF and NYHA class significantly improved at 6 months after the CA in 12 patients (67 %) who were in SR or had recurrent paroxysmal AF (from 25.8 ± 6.3 to 37.0 ± 11.7 %, P = 0.02, and from 2.3 ± 0.5 to 1.5 ± 0.7, P < 0.01, respectively) but not in patients who experienced recurrent persistent AF. The patients with SR or recurrent paroxysmal AF had significantly fewer hospitalizations for HF than those with recurrent persistent AF after the AF ablation (log-rank test; P < 0.01). Catheter ablation of AF improved the clinical status in patients with an LVEF of ≤ 35 %. A repeat ablation procedure and amiodarone were often necessary to obtain a favorable outcome.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation III: Medical Management

